Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Nederlandse hepatologie in historisch en toekomstig perspectief hoofdstuk lezen eerste hoofdstuk lezen

2009 | OriginalPaper | Hoofdstuk

18 Parasitaire, bacteriële en schimmelinfecties van de lever

Auteurs : Dr. L.G. Visser, Dr. J.W. van ’t Wout

Gepubliceerd in: Leverziekten

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

In dit hoofdstuk worden de meest voorkomende parasitaire infecties van de lever behandeld, te weten echinococcose, het door amoeben veroorzaakte leverabces (amoebiasis), schistosomiasis en parasitaire cholangiohepatitis. Daarna komen de door bacteriën veroorzaakte pyogene leverabcessen aan bod en tot slot worden schimmelinfecties van de lever en granulomateuze hepatitis besproken.
vorige hoofdstuk 17 Levercysten
volgende hoofdstuk 19 Cholelithiasis, cholecystitis en cholangitis
Literatuur
1.
Romig T, Dinkel A, Mackenstedt U. The present situation of echinococcus in Europe. Parasitol Int 2006;55:S187–S191.PubMedCrossRef
2.
3.
Yalin R, Aktan Ő , et al. Significance of intracystic pressure in abdominal hydatid disease. Br J Surg 1992; 79:1182–1183.PubMedCrossRef
4.
5.
Mortelé KJ, Segatto E, et al. The infected liver: radiologic- pathologic correlation. Radiographics 2004;24: 937–955.PubMedCrossRef
6.
Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS, eds. France. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. Gene`ve: WHO, 2001.
7.
WHO informal working group on echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull WHO 1996;74:231–242.
8.
Smego RA, Bhatti S, et al. Percutaneous aspirationinjection- reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a metaanalysis. Clin Infect Dis 2003;37:1073–1083.PubMedCrossRef
9.
Dziri C, Karim Haouet FACS, et al. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg 2004;28:731–736.PubMedCrossRef
10.
Schipper HG, Laméris JS, et al. Percutaneous evacuation (PEVAC) of multivesicular echinococcal cysts with or without cystobiliary fistulas which contain nondrainable material: first results of a modified PAIR method. Gut 2002;50:718–723.PubMedCentralPubMedCrossRef
11.
Jung H, Medina L, et al. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. J Pharm Pharmacol 1998;50:43–48.PubMedCrossRef
12.
Edwards G, Beckenridge AM. Clincial pharmacokinetics of antihelmintic drugs. Clin Pharmacokinet 1988; 15:67–93.PubMed
13.
Franchi C, Di Vico B, et al. Long-term evaluation of patiens with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis 1999;29:304–309.PubMedCrossRef
14.
Taylor DH, Morris DL, et al. Combination chemotherapy of Echinococcus granulosus -- in vitro studies. Trans Roy Soc Trop Med Hyg 1988;82:263–264.PubMedCrossRef
15.
Taylor DH, Morris DL, et al. Echinococcus granulosus: in vitromaintenance of whole cysts and the assessment of the effects of albendazole sulphoxide and praziquantel on the germinal layer. Trans Roy Soc Trop Med Hyg 1988;82:263–264.PubMedCrossRef
16.
Taylor DH, Morris DL. Combination chemotherapy is more effective in postspillage prophylaxis for hydatid diseases than either albendazole or praziquantel alone. Br J Surg 1989;76:954.PubMedCrossRef
17.
Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, et al. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis 2004;10:2088–2093.PubMedCentralPubMed
18.
Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet JP, et al. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006;55; S267–S272.PubMedCrossRef
19.
Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006;55:S283–S287.PubMedCrossRef
20.
Koch S, Bresson-Hadni S, Miguet JP, Crumbach JP, Gillet M, Mantion GA, et al. European Collaborating Clinicians. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation 2003;75:856–863.PubMedCrossRef
21.
22.
23.
Velde LF te, Blaauwwiekel EE, Sprenger HG, Weits J. Een amoebenabces in de lever; vroeg vermoeden, late detectie. Ned Tijdschr Geneeskd 1997;141:1436–1439.
24.
Sachdev GK, Dhol P. Colonic involvement in patients with amebic liver abscess: endoscopic findings. Gastrointest Endosc 1997;46:37–39.PubMedCrossRef
25.
Blessmann J, Duy Binh H. Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study. Trop Med Int Health 2003;8:1030–1034.PubMedCrossRef
26.
Gool T van, Peek R, et al. Ingezonden mededeling. Ned Tijdschr Geneeskd 2005;149:53–54.PubMed
27.
Kager P. Ingezonden mededeling. Ned Tijdschr Geneeskd 2005;149:51–53.PubMed
28.
Visser LG, Verweij JJ, Van Esbroeck M, Edeling WM, Clerinx J, Polderman AM. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a nonendemic setting. Int J Med Microbiol 2006;296:397–403.PubMedCrossRef
29.
Edeling WM, Verweij JJ, Ponsioen CI, Visser LG. Uitbraak van amoebiasis in een Nederlands gezin; tropen onverwacht dichtbij. Ned Tijdschr Geneeskd 2005;148: 1830–1834.
30.
Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 1995;20:280–285.PubMedCrossRef
31.
32.
Dunne DW, Pearce EJ. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect 1999;1:553–560.PubMedCrossRef
33.
Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887–891.PubMedCrossRef
34.
Lieshout L van, Polderman AM, Deelder AM. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop 2000;77(1):69–78.PubMedCrossRef
35.
Visser LG. Hoe stelt men de diagnose schistosomiasis en hoe is de behandeling? Internisten Vademecum 2006;11(8).
36.
Cançado JR, Da Cunha AS, De Carvalho DG, Cambria NS. Evalutation of the treatment of human Schistosoma mansoni infection by quantitative oogram technique. Bull WHO 1965;33:557–566.PubMedCentralPubMed
37.
Abdel-Wahab MF, Esmat G, Farrag A, el-Boraey Y, Strickland GT. Ultrasonographic prediction of esophageal varices in Schistosomiasis mansoni. Am J Gastroenterol 1993;88:560–563.PubMed
38.
Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med 2002; 346:1212–1220.PubMedCrossRef
39.
Richter J. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 2000;77(1):111–131.PubMedCrossRef
40.
Kiire CF. Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. BMJ 1989;298(6684):1363–1365.PubMedCentralPubMedCrossRef
41.
Gawish Y, El-Hammadi HA, Kotb M, Awad AT, Anwar M. Devascularization procedure and DSRS: a controlled randomized trial on selected haemodynamic portal flow pattern in schistosomal portal hypertension with variceal bleeding. Int Surg 2000;85:325–330.PubMed
42.
Silva LC da, Strauss E, Gayotto LC, Mies S, Macedo AL, Silva AT da, et al. A randomized trial for the study of the elective surgical treatment of portal hypertension in mansonic schistosomiasis. Ann Surg 1986;204:148–153.PubMedCentralPubMedCrossRef
43.
Hurtad RM, Sahani DV, Kradin R. Case 9-2006: a 35- year-old woman with recurrent right-upper-quadrant pain. N Engl J Med 2006;354:1295–2130.CrossRef
44.
45.
Lim JH, Kim SY, Park CM. Parasitic diseases of the biliary tract. American Journal Radiology 2007;188: 1596–1603.
46.
Shah OJ, Zargar SA, Robbani I. Biliary ascariasis: a review. World J Surgery 2006;30:1500–1506.CrossRef
47.
Lun ZR, Gasser RB, Lai DH, Li AX, Yu XB, Fang YY. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005;5:31–41.PubMedCrossRef
48.
Talaie H, Emami H, Yadegarinia D, Nava-Ocampo AA, Massoud J, Azmoudeh M, et al. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis. Clin Exp Pharmacol Physiol 2004;31:777–782.PubMedCrossRef
49.
Favennec L, Jave Ortiz J, Gargala G, Lopez Chegne N, Ayoub A, Rossignol JF. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 2003;17:265–270.PubMedCrossRef
50.
Hien TT, Truong NT, Minh NH, Dat HD, Dung NT, Hue NT, et al. Randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am J Trop Med Hyg 2008;78: 388–392.PubMed
51.
Keiser J, Utzinger J. Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol 2007;23:555–562.PubMedCrossRef
52.
Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Inf Dis Clin N Am 2000;14:547–563.CrossRef
53.
Chen SC, Tsai SJ, Chen CH, Huang CC, Lin DB, Wang PH, et al. Predictors of mortality in patients with pyogenic liver abscess. Neth J Med 2008;66:196–203.PubMed
54.
Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess. AJR 2007;189: W138–W142.PubMedCrossRef
55.
Rajak CL, Gupta S, Jain S, Chawla Y, Gulati M, Suri S. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR 1998;170:1035–1039.PubMedCrossRef
56.
Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis: a manifestation of chronic disseminated candidiasis. Infect Dis Clin N Am 2000; 14:721–739.CrossRef
57.
Fauci AS, Hoffman GS. Granulomatous hepatitis. In: Mandell GR, Douglass RG, Bennett JE, editors. Principles and practice of infectious diseases, pp. 1024–1028. 3rd ed, 1990.
Metagegevens
Titel
18 Parasitaire, bacteriële en schimmelinfecties van de lever
Auteurs
Dr. L.G. Visser
Dr. J.W. van ’t Wout
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leverziekten

Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009

DOI
https://doi.org/10.1007/978-90-313-7437-3_18